223 related articles for article (PubMed ID: 37300820)
21. Isavuconazole in a Successful Combination Treatment of Disseminated Mucormycosis in a Child with Acute Lymphoblastic Leukaemia and Generalized Haemochromatosis: A Case Report and Review of the Literature.
Pomorska A; Malecka A; Jaworski R; Radon-Proskura J; Hare RK; Nielsen HV; Andersen LO; Jensen HE; Arendrup MC; Irga-Jaworska N
Mycopathologia; 2019 Feb; 184(1):81-88. PubMed ID: 30039238
[TBL] [Abstract][Full Text] [Related]
22. [Mucormycosis: therapeutic news].
Pilmis B; Lanternier F; Lortholary O
Med Sci (Paris); 2013 Mar; 29 Spec No 1():25-30. PubMed ID: 23510522
[TBL] [Abstract][Full Text] [Related]
23. Successful Isavuconazole therapy in a patient with acute invasive fungal rhinosinusitis and acquired immune deficiency syndrome.
Ahmed Y; Delaney S; Markarian A
Am J Otolaryngol; 2016; 37(2):152-5. PubMed ID: 26954873
[TBL] [Abstract][Full Text] [Related]
24. An Unusual Case of Pulmonary Mucormycosis.
Thomas S; Pawar B; Fernandes D; Nayar S; George P; Cherian S
Transplant Proc; 2018 Dec; 50(10):3943-3945. PubMed ID: 30503525
[TBL] [Abstract][Full Text] [Related]
25. [Expert consensus on diagnosis and treatment of severe COVID-19 associated pulmonary
;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jan; 47(1):10-23. PubMed ID: 38062689
[TBL] [Abstract][Full Text] [Related]
26. A case of mistaken identity:
Chen AJ; Ediriwickrema LS; Verma R; Vavinskaya V; Shaftel S; Deconde AS; Korn BS; Kikkawa DO; Liu CY
Orbit; 2021 Dec; 40(6):521-524. PubMed ID: 32862746
[TBL] [Abstract][Full Text] [Related]
27. [Non-fatal disseminated mucormycosis in a solid organ transplant].
Minet C; Bonadona A; Tabah A; Karkas A; Mescam L; Schwebel C; Hamidfar R; Pison C; Saint-Raymond C; Faure O; Salameire D; Timsit JF
Rev Mal Respir; 2009 Nov; 26(9):998-1002. PubMed ID: 19953048
[TBL] [Abstract][Full Text] [Related]
28. [Mucormycosis: Current and future management perspective].
Martín Gómez MT; Salavert Lletí M
Rev Iberoam Micol; 2021; 38(2):91-100. PubMed ID: 34144835
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia.
Rickerts V; Atta J; Herrmann S; Jacobi V; Lambrecht E; Bialek R; Just-Nübling G
Mycoses; 2006; 49 Suppl 1():27-30. PubMed ID: 16961579
[TBL] [Abstract][Full Text] [Related]
30. Galleria mellonella as a model system to study virulence potential of mucormycetes and evaluation of antifungal treatment.
Maurer E; Hörtnagl C; Lackner M; Grässle D; Naschberger V; Moser P; Segal E; Semis M; Lass-Flörl C; Binder U
Med Mycol; 2019 Apr; 57(3):351-362. PubMed ID: 29924357
[TBL] [Abstract][Full Text] [Related]
31. Our 2014 approach to mucormycosis.
Tacke D; Koehler P; Markiefka B; Cornely OA
Mycoses; 2014 Sep; 57(9):519-24. PubMed ID: 24829170
[TBL] [Abstract][Full Text] [Related]
32. Latest Thoughts on Treating Pediatric Mucormycosis.
Steinbach WJ
J Pediatric Infect Dis Soc; 2020 Nov; 9(5):640-644. PubMed ID: 33043976
[TBL] [Abstract][Full Text] [Related]
33. Experimental murine model of disseminated infection by Saksenaea vasiformis: successful treatment with posaconazole.
Salas V; Pastor FJ; Calvo E; Sutton D; García-Hermoso D; Mayayo E; Dromer F; Fothergill A; Alvarez E; Guarro J
Med Mycol; 2012 Oct; 50(7):710-5. PubMed ID: 22458251
[TBL] [Abstract][Full Text] [Related]
34. Mucormycosis in renal transplant recipients: review of 174 reported cases.
Song Y; Qiao J; Giovanni G; Liu G; Yang H; Wu J; Chen J
BMC Infect Dis; 2017 Apr; 17(1):283. PubMed ID: 28420334
[TBL] [Abstract][Full Text] [Related]
35. Disseminated Mucormycosis With Cerebral Involvement Owing to Rhizopus Microsporus in a Kidney Recipient Treated With Combined Liposomal Amphotericin B and Posaconazole Therapy.
Ville S; Talarmin JP; Gaultier-Lintia A; Bouquié R; Sagan C; Le Pape P; Giral M; Morio F
Exp Clin Transplant; 2016 Feb; 14(1):96-9. PubMed ID: 25275881
[TBL] [Abstract][Full Text] [Related]
36. Contemporary management and clinical outcomes of mucormycosis: A systematic review and meta-analysis of case reports.
Jeong W; Keighley C; Wolfe R; Lee WL; Slavin MA; Chen SC; Kong DCM
Int J Antimicrob Agents; 2019 May; 53(5):589-597. PubMed ID: 30639526
[TBL] [Abstract][Full Text] [Related]
37. Clinical experience with posaconazole in patients with invasive mucormycosis: a case series.
González-Ramos MM; Bertrán-Pasarell J; Guiot H; Soto R; Santana J; Amador R; Conde A
P R Health Sci J; 2008 Dec; 27(4):328-32. PubMed ID: 19069358
[TBL] [Abstract][Full Text] [Related]
38. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran.
Abdorahimi M; Pakdel F; Salehi M; Alcazar-Fuoli L; Hashemi SJ; Daie Ghazvini R; Ahmadkhani F; Ahmadikia K; Abdollahi A; Debran JCS; Tabari A; Farrokh F; Mousavand A; Afarinesh Khaki P; Salami Khaneshan A; Ibrahim AS; Khodavaisy S
Mycopathologia; 2023 Oct; 188(5):783-792. PubMed ID: 37672164
[TBL] [Abstract][Full Text] [Related]
39. [Not Available].
Gholinejad Ghadi N; Seifi Z; Shokohi T; Aghili SR; Nikkhah M; Vahedi Larijani L; Ghasemi M; Haghani I
J Mycol Med; 2018 Jun; 28(2):399-402. PubMed ID: 29545122
[TBL] [Abstract][Full Text] [Related]
40. Successful treatment of cutaneous mucormycosis disseminated from pulmonary mucormycosis with liposomal amphotericin B and posaconazole.
Ding XL; Li HM; Du J
Chin Med J (Engl); 2020 Jul; 133(14):1747-1748. PubMed ID: 32590461
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
